Valence 標誌
熱門
登入

加入到自選清單

DaVita Inc.

NYSE: DVA · 即時價格 · USD
177.99
+1.29 (0.73%)
收盤時： Aug 18, 2026, 10:36 AM

DaVita Inc. (DVA) Stock Price, Analysis & Data

0.73%
買價178.45
市值11.36B
營收 (ttm)14.01B
淨利（ttm）822.48M
貝塔0.87
EPS (ttm)11.8
本益比（ttm）15.08
正向 PE10.46
P/B (ttm)-14.88
P/S (ttm)0.82
Earnings DateOct 28, 2026
賣價178.86
成交量44,852
20 日平均成交量885,553
打開178.13
上一頁關閉176.70
日間範圍177.99 - 179.83
52 週範圍101.00 - 247.49
分析師Buy
目標價220 (23.60%)
股利n/a
Ex-股利日期n/a

關於DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory te...

[閱讀更多]
工業 Medical Care Facilities
部門 Healthcare
IPO 日期 Oct 31, 1995
員工 78,000
證券交易所 NYSE
股票代號 DVA
網站 https://www.davita.com
完整的公司簡介

財務表現

DaVita 在 2025 年的營收為 13.64B，較前一年的 12.82B 增加 6.46%。 淨利為 746.8M，較前期減少 -20.24%。

財務報表

分析師預測

根據7 分析師評等，DVA股票的平均評等為「Buy」。 12個月股價預測為220，與最新價格相比為上漲空間的23.6%。

股票預測

獲利驚喜

DaVita 已於 Aug 4, 2026 公布季度財報：
  • 營收的 n/a 錯過估計 $0, 與 -100.00% YoY 下降.
  • EPS 的 4.02 超出估計 0.14, 與 36.27% YoY 成長.

    • 下次財報發布

    DaVita Inc. 定於發布財報 Oct 28, 2026, 收盤後。
    分析師預估營收 ... 升級
    news image

    3 天 前 · The Wall Street Journal

    Berkshire Adds to Alphabet Stake, Buys Home Builders and Exits Constellation

    Greg Abel—CEO and top stock picker—reduced the company’s portfolio in financial shares during the second quarter.

    news image

    3 天 前 · Yahoo Finance Video

    Berkshire ups Alphabet stake under Greg Abel, making it a top-3 holding

    Berkshire Hathaway (BRK-A, BRK-B), under new CEO Greg Abel, increased its Alphabet position, making the Google parent its third-largest U.S.-listed equity holding by market value, behind Apple (AAPL) ...

    news image

    5 天 前 · StockStory

    The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call

    DaVita’s second quarter results surpassed Wall Street’s revenue and adjusted profit expectations, but the market response was notably negative. Management attributed this to a mix of operational and i...

    news image

    5 天 前 · Bloomberg

    S&P 500 Earnings Are So Good Investors Are Starting to Worry

    (Bloomberg) -- The latest reason to worry about the stock market is quite the doozy: Earnings growth has been too strong. Most Read from BloombergPhoebe Gates Knew Phia Shopping App Took Credit for Sa...

    news image

    6 天 前 · Motley Fool

    DaVita (DVA) Q2 2026 Earnings Call Transcript

    Mortality gains drove treatment growth despite payor mix headwinds.

    第 1 頁，共 2 頁